Exploring the mechanisms of action of Zengye decoction (ZYD) against Sjogren’s syndrome (SS) using network pharmacology and animal experiment

References

• Ahmad Khan M, Sarwar A, Rahat R, Ahmed RS, Umar S. 2020. Stigmasterol protects rats from collagen induced arthritis by inhibiting proinflammatory cytokines. Int Immunopharmacol. 85:106642. doi: 10.1016/j.intimp.2020.106642.
   PubMed Web of Science ®Google Scholar
• Aubin AM, Lombard-Vadnais F, Collin R, Aliesky HA, McLachlan SM, Lesage S. 2022. The NOD mouse beyond autoimmune diabetes. Front Immunol. 13:874769. doi: 10.3389/fimmu.2022.874769.
   PubMed Web of Science ®Google Scholar
• Awad A, Fink C. 2000. Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr. 130(9):2127–2130. doi: 10.1093/jn/130.9.2127.
   PubMed Web of Science ®Google Scholar
• Bartoloni E, Alunno A, Gerli R. 2019. The dark side of Sjogren’s syndrome: the possible pathogenic role of infections. Curr Opin Rheumatol. 31(5):505–511. doi: 10.1097/BOR.0000000000000631.
   PubMed Web of Science ®Google Scholar
• Birnbaum J, Lalji A, Saed A, Baer AN. 2019. Biopsy-proven small-fiber neuropathy in primary Sjogren’s syndrome: neuropathic pain characteristics, autoantibody findings, and histopathologic features. Arthritis Care Res. 71(7):936–948. doi: 10.1002/acr.23762.
   Web of Science ®Google Scholar
• Boumba D, Skopouli F, Moutsopoulos H. 1995. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren’s syndrome. Br J Rheumatol. 34(4):326–333. doi: 10.1093/rheumatology/34.4.326.
   PubMedGoogle Scholar
• Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M. 2016. Sjogren syndrome. Nat Rev Dis Primers. 2:16047. doi: 10.1038/nrdp.2016.47.
   PubMed Web of Science ®Google Scholar
• Chan, BKC. 2018. Data analysis using R programming. Adv Exp Med Biol. 1082:47–122.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang YH, Wang S, Zhang Y, Huang T, Cai YD. 2017. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLOS One. 12(9):e0184129. doi: 10.1371/journal.pone.0184129.
   PubMed Web of Science ®Google Scholar
• Chisholm D, Mason D. 1968. Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol. 21(5):656–660. doi: 10.1136/jcp.21.5.656.
   PubMed Web of Science ®Google Scholar
• Chowdhury F, Tappuni A, Bombardieri M. 2021. Biological therapy in primary Sjogren’s syndrome: effect on salivary gland function and inflammation. Front Med. 8:707104. doi: 10.3389/fmed.2021.707104.
   Web of Science ®Google Scholar
• Demchak B, Otasek D, Pico AR, Bader GD, Ono K, Settle B, Sage E, Morris JH, Longabaugh W, Lopes C, et al. 2018. The cytoscape automation app article collection. F1000Res. 7:800. doi: 10.12688/f1000research.15355.1.
   PubMedGoogle Scholar
• Fox RI. 2005. Sjögren’s syndrome. Lancet. 366(9482):321–331. doi: 10.1016/S0140-6736(05)66990-5.
   PubMed Web of Science ®Google Scholar
• Fox RI, Fox CM, Gottenberg JE, Dorner T. 2021. Treatment of Sjogren’s syndrome: current therapy and future directions. Rheumatology. 60(5):2066–2074. doi: 10.1093/rheumatology/kez142.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. 2005. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren’s syndrome. J Autoimmun. 24(3):235–242. doi: 10.1016/j.jaut.2005.01.015.
   PubMed Web of Science ®Google Scholar
• Huang H, Xie W, Geng Y, Fan Y, Zhang Z. 2021. Mortality in patients with primary Sjogren’s syndrome: a systematic review and meta-analysis. Rheumatology. 60(9):4029–4038. doi: 10.1093/rheumatology/keab364.
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, Falk SS, Liu Y, Szodoray P, Takakubo Y. 2012. Sex steroids in Sjogren’s syndrome. J Autoimmun. 39(1–2):49–56. doi: 10.1016/j.jaut.2012.01.004.
   PubMed Web of Science ®Google Scholar
• Le CF, Kailaivasan TH, Chow SC, Abdullah Z, Ling SK, Fang CM. 2017. Phytosterols isolated from Clinacanthus nutans induce immunosuppressive activity in murine cells. Int Immunopharmacol. 44:203–210. doi: 10.1016/j.intimp.2017.01.013.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang B. 2013. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 11(2):110–120. doi: 10.1016/S1875-5364(13)60037-0.
   PubMed Web of Science ®Google Scholar
• Li CY, Wu SL, Sun LX, Yan TT, Wang Y. 2019. Protective effect of zengye decoction on submandibular glands in nonobese diabetic mice. Chin J Integr Med. 25(1):45–50. doi: 10.1007/s11655-014-1981-5.
   PubMed Web of Science ®Google Scholar
• Li N, Li L, Wu M, Li Y, Yang J, Wu Y, Xu H, Luo D, Gao Y, Fei X. 2021. Integrated bioinformatics and validation reveal potential biomarkers associated with progression of primary Sjogren’s syndrome. Front Immunol. 12:697157. doi: 10.3389/fimmu.2021.697157.
   PubMed Web of Science ®Google Scholar
• Lin X, Song JX, Shaw PC, Ng TB, Wong RN, Sze SC, Tong Y, Lee KF, Zhang KY. 2011. An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjogren’s syndrome. Int Immunol. 23(10):613–624. doi: 10.1093/intimm/dxr066.
   PubMed Web of Science ®Google Scholar
• Liu D, Lin L, Lin Y, Zhong Y, Zhang S, Liu W, Zou B, Liao Q, Xie Z. 2019. Zengye decoction induces alterations to metabolically active gut microbiota in aged constipated rats. Biomed Pharmacother. 109:1361–1371. doi: 10.1016/j.biopha.2018.11.013.
   PubMed Web of Science ®Google Scholar
• Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, Diao L, Gu J, Wang W, Li D, et al. 2016. BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine. Sci Rep. 6:21146. doi: 10.1038/srep21146.
   PubMed Web of Science ®Google Scholar
• Luo TT, Lu Y, Yan SK, Xiao X, Rong XL, Guo J. 2020. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective. Chin J Integr Med. 26(1):72–80. doi: 10.1007/s11655-019-3064-0.
   PubMed Web of Science ®Google Scholar
• Maehara T, Moriyama M, Hayashida JN, Tanaka A, Shinozaki S, Kubo Y, Matsumura K, Nakamura S. 2012. Selective localization of T helper subsets in labial salivary glands from primary Sjögren’s syndrome patients. Clin Exp Immunol. 169(2):89–99. doi: 10.1111/j.1365-2249.2012.04606.x.
   PubMed Web of Science ®Google Scholar
• Manganelli P, Fietta P. 2003. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum. 33(1):49–65. doi: 10.1053/sarh.2003.50019.
   PubMed Web of Science ®Google Scholar
• Mavragani CP, Moutsopoulos HM. 2020. Sjogren’s syndrome: old and new therapeutic targets. J Autoimmun. 110:102364. doi: 10.1016/j.jaut.2019.102364.
   PubMed Web of Science ®Google Scholar
• Minghao L, Weina D, Zhenling Z. 2016. Research progress in clinical application of zengyetang. Acta Chinese Med. 31:1525–1528.
   Google Scholar
• Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, et al. 2005. The wide spectrum of clinical manifestations in Sjogren’s syndrome-associated neuropathy. Brain. 128(Pt 11):2518–2534. doi: 10.1093/brain/awh605.
   PubMed Web of Science ®Google Scholar
• Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, Indiveri F, Puppo F. 2022. Sjogren’s syndrome: a systemic autoimmune disease. Clin Exp Med. 22(1):9–25. doi: 10.1007/s10238-021-00728-6.
   PubMed Web of Science ®Google Scholar
• Norheim KB, Jonsson G, Harboe E, Hanasand M, Goransson L, Omdal R. 2012. Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren’s syndrome. Free Radic Res. 46(2):141–146. doi: 10.3109/10715762.2011.645206.
   PubMed Web of Science ®Google Scholar
• Paniagua-Perez R, Flores-Mondragon G, Reyes-Legorreta C, Herrera-Lopez B, Cervantes-Hernandez I, Madrigal-Santillan O, Morales-Gonzalez JA, Alvarez-Gonzalez I, Madrigal-Bujaidar E. 2017. Evaluation of the anti-inflammatory capacity of beta-sitosterol in rodent assays. Afr J Tradit Complement Altern Med. 14(1):123–130. doi: 10.21010/ajtcam.v14i1.13.
   PubMedGoogle Scholar
• Pollard RP, Abdulahad WH, Bootsma H, Meiners PM, Spijkervet FK, Huitema MG, Burgerhof JG, Vissink A, Kroese FG. 2013. Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 72(12):2048–2050. doi: 10.1136/annrheumdis-2013-203447.
   PubMed Web of Science ®Google Scholar
• Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, Degn SE, Georgiou P, Mouzaki A. 2018. Clinical and immunological parameters of Sjögren’s syndrome. Autoimmun Rev. 17(10):1053–1064. doi: 10.1016/j.autrev.2018.05.005.
   PubMed Web of Science ®Google Scholar
• Roescher N, Tak PP, Illei GG. 2010. Cytokines in Sjögren’s syndrome: potential therapeutic targets. Ann Rheum Dis. 69(6):945–948. doi: 10.1136/ard.2009.115378.
   PubMed Web of Science ®Google Scholar
• Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:13. doi: 10.1186/1758-2946-6-13.
   PubMed Web of Science ®Google Scholar
• Ryo K, Yamada H, Nakagawa Y, Tai Y, Obara K, Inoue H, Mishima K, Saito I. 2006. Possible involvement of oxidative stress in salivary gland of patients with Sjogren’s syndrome. Pathobiology. 73(5):252–260. doi: 10.1159/000098211.
   PubMed Web of Science ®Google Scholar
• Saikia S, Bordoloi M. 2019. Molecular docking: challenges, advances and its use in drug discovery perspective. CDT. 20(5):501–521. doi: 10.2174/1389450119666181022153016.
   Google Scholar
• Saito M, Otsuka K, Ushio A, Yamada A, Arakaki R, Kudo Y, Ishimaru N. 2018. Unique phenotypes and functions of follicular helper T cells and regulatory T cells in Sjögren’s syndrome. Curr Rheumatol Rev. 14(3):239–245. doi: 10.2174/1573397113666170125122858.
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, et al. 2017. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 69(1):35–45. doi: 10.1002/art.39859.
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Gamaletsou MN, Moutsopoulos HM. 2011. Is Sjögren’s syndrome a retroviral disease? Arthritis Res Ther. 13(2):212. doi: 10.1186/ar3262.
   PubMed Web of Science ®Google Scholar
• Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein T, Nudel R, Lieder I, Mazor Y, et al. 2016. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 54:1.30.31–31.30.33.
   Google Scholar
• Sun L, Qin P, Zhang L, Sun H. 2015. Researches on the zengye tang in the influences of TNF-α and IL-1β over the SS rats. Western J Trad Chinese Med. 28:13–14.
   Google Scholar
• Vivino FB. 2017. Sjogren’s syndrome: clinical aspects. Clin Immunol. 182:48–54. doi: 10.1016/j.clim.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Wakamatsu TH, Dogru M, Matsumoto Y, Kojima T, Kaido M, Ibrahim OM, Sato EA, Igarashi A, Ichihashi Y, Satake Y, et al. 2013. Evaluation of lipid oxidative stress status in Sjogren syndrome patients. Invest Ophthalmol Vis Sci. 54(1):201–210. doi: 10.1167/iovs.12-10325.
   PubMed Web of Science ®Google Scholar
• Wang G, Qi WX, Yan YF, Wang T, Zou FX. 2021. Mechanism of Chinese medicine against Sjögren syndrome: a review. Chinese J of Exper Trad Med Formulae. 27(20):227–235.
   Google Scholar
• Wang M, Chang SQ, Tian YS, Zhang GQ, Qi J. 2020. Zengye decoction ameliorates insulin resistance by promoting glucose uptake. Rejuvenation Res. 23(5):367–376. doi: 10.1089/rej.2019.2228.
   PubMed Web of Science ®Google Scholar
• Wei S, He Q, Zhang Q, Fu K, Li R, Peng W, Gao Y. 2021. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren’s syndrome: a review. J Integr Med. 19(3):191–202. doi: 10.1016/j.joim.2021.01.008.
   PubMedGoogle Scholar
• Yanagisawa N, Ueshiba H, Abe Y, Kato H, Higuchi T, Yagi J. 2018. Outer membrane protein of gut commensal microorganism induces autoantibody production and extra-intestinal gland inflammation in mice. Int J Mol Sci. 19:3241. doi: 10.3390/ijms19103241.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yu D, Zhang Y. 2019. Beta-sitosterol attenuates the intracranial aneurysm growth by suppressing TNF-alpha-mediated mechanism. Pharmacology. 104(5-6):303–311. doi: 10.1159/000502221.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hou Y, Li J, Zhang F, Du Q. 2020. Characterization of antiapoptotic microRNAs in primary Sjogren’s syndrome. Cell Biochem Funct. 38(8):1111–1118. doi: 10.1002/cbf.3569.
   PubMedGoogle Scholar
• Yuewen L, Zhiqiang, L, Bolong W. 2018. Study on network target prediction and action mechanism of Zengye decoction. Chin J Mod Appl Pharm. 35:1842–1848.
   Google Scholar
• Zhang R, Zhu X, Bai H, Ning K. 2019. Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol. 10:123. doi: 10.3389/fphar.2019.00123.
   PubMed Web of Science ®Google Scholar
• Zhang S. 2011. The TCM etiology, pathogenesy and differential treatment for Sjogren’s syndrome. J Tradit Chin Med. 31(1):73–78. doi: 10.1016/s0254-6272(11)60017-4.
   PubMed Web of Science ®Google Scholar
• Zheng LW, Hua H, Cheung LK. 2011. Traditional Chinese medicine and oral diseases: today and tomorrow. Oral Dis. 17(1):7–12. doi: 10.1111/j.1601-0825.2010.01706.x.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou Q, Li JG, Liu RL. 2020. Effect of zengye runzao decoction on INF-γ, TNF-α and aquaporin in submandibular gland of Sjogren’s syndrome model mice. Acta Chinese Med. 35:2407–2410.
   Google Scholar